Literature DB >> 19638070

Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study.

Jorge Albores-Saavedra1, Kristen Batich, Freddy Chable-Montero, Noa Sagy, Arnold M Schwartz, Donald Earl Henson.   

Abstract

BACKGROUND: Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor arising predominantly on sun-exposed skin of older and usually immunosuppressed individuals.
METHODS: Using data from NCI's SEER (Surveillance, Epidemiology, and End Results) Program from 1973 to 2006, we analyzed the demographics and survival of MCC.
RESULTS: SEER had recorded 3870 cases of MCC. The incidence was higher in men (2380 cases, 61.5%) than in women (1490 cases, 38.5%). Most patients were White (94.9%) between 60 and 85 years of age. MCC was rare in Blacks. The most common location was the head and neck. The salivary glands, nasal cavity, lip, lymph nodes, vulva, vagina and esophagus were the most common extracutaneous sites. The 10-year relative survival rate was higher in women than men (64.8% vs. 50.5%, p < 0.001). Patients 50-69 years had the highest 10-year relative survival rate (59.6%). Stage of disease was the best predictor of survival.
CONCLUSIONS: MCC arises predominantly in the skin of head and neck in White men above 70 years of age. Cases also occurred in extracutaneous sites. Age did not predict survival, yet gender, site and tumor size revealed clear differences. The most significant predictor of survival was tumor stage.
Copyright © 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2009        PMID: 19638070     DOI: 10.1111/j.1600-0560.2009.01370.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  147 in total

1.  Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen.

Authors:  Stephanie K Demetriou; Katherine Ona-Vu; Erin M Sullivan; Tiffany K Dong; Shu-Wei Hsu; Dennis H Oh
Journal:  Int J Cancer       Date:  2012-05-29       Impact factor: 7.396

2.  Activation of PI3K signaling in Merkel cell carcinoma.

Authors:  Valentina Nardi; Youngchul Song; Juan A Santamaria-Barria; Arjola K Cosper; Quynh Lam; Anthony C Faber; Genevieve M Boland; Beow Y Yeap; Kristin Bergethon; Vanessa L Scialabba; Hensin Tsao; Jeffrey Settleman; David P Ryan; Darrell R Borger; Atul K Bhan; Mai P Hoang; Anthony J Iafrate; James C Cusack; Jeffrey A Engelman; Dora Dias-Santagata
Journal:  Clin Cancer Res       Date:  2012-01-18       Impact factor: 12.531

Review 3.  Merkel cell carcinoma: what do we know about it and what should we do?

Authors:  Isabel Prieto Muñoz; José Pardo Masferrer; Jesús Olivera Vegas; José Ramón Fortes Alen; Ana M Pérez Casas
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

Review 4.  Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.

Authors:  Shailender Bhatia; Olga Afanasiev; Paul Nghiem
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

5.  Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system.

Authors:  Bianca D Lemos; Barry E Storer; Jayasri G Iyer; Jerri Linn Phillips; Christopher K Bichakjian; L Christine Fang; Timothy M Johnson; Nanette J Liegeois-Kwon; Clark C Otley; Kelly G Paulson; Merrick I Ross; Siegrid S Yu; Nathalie C Zeitouni; David R Byrd; Vernon K Sondak; Jeffrey E Gershenwald; Arthur J Sober; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2010-06-19       Impact factor: 11.527

6.  Merkel cell carcinoma of unknown primary origin.

Authors:  Jeremiah L Deneve; Jane L Messina; Suroosh S Marzban; Ricardo J Gonzalez; Brooke M Walls; Kate J Fisher; Y Ann Chen; C Wayne Cruse; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2012-01-21       Impact factor: 5.344

Review 7.  Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.

Authors:  Aric Colunga; Thomas Pulliam; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

Review 8.  Update on Merkel Cell Carcinoma.

Authors:  Michael T Tetzlaff; Priyadharsini Nagarajan
Journal:  Head Neck Pathol       Date:  2018-03-20

Review 9.  Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Authors:  Daniela Femia; Natalie Prinzi; Andrea Anichini; Roberta Mortarini; Federico Nichetti; Francesca Corti; Martina Torchio; Giorgia Peverelli; Filippo Pagani; Andrea Maurichi; Ilaria Mattavelli; Massimo Milione; Nice Bedini; Ambra Corti; Maria Di Bartolomeo; Filippo de Braud; Sara Pusceddu
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

10.  Clinical, dermoscopic and histological features of a Merkel cell carcinoma of the hand.

Authors:  Massimiliano Scalvenzi; Franco Palmisano; Gennaro Ilardi; Silvia Varricchio; Claudia Costa
Journal:  J Dermatol Case Rep       Date:  2013-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.